IGC Pharma, Inc. (IGC): Cash & Equivalents
Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$405.0K
As of 2025-03-31
-66.2%
3-year compound annual growth
-43.9%
5-year compound annual growth
-6.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-03-31 | $405.0K | -66.2% | 2025-06-27, Balance as of period end |
| 2024-03-31 | $1.20M | -62.5% | 2025-06-27, Balance as of period end |
| 2023-03-31 | $3.20M | -69.4% | 2024-06-24, Balance as of period end |
| 2022-03-31 | $10.46M | -28.1% | 2023-07-07, Balance as of period end |
| 2021-03-31 | $14.55M | +100.4% | 2022-06-23, Balance as of period end |
| 2020-03-31 | $7.26M | -71.7% | 2021-06-14, Balance as of period end |
| 2019-03-31 | $25.61M | n/m | 2020-07-13, Balance as of period end |
| 2018-03-31 | $1.66M | +208.2% | 2019-06-14, Balance as of period end |
| 2017-03-31 | $538.0K | -63.9% | 2018-06-21, Balance as of period end |
| 2016-03-31 | $1.49M | +80.8% | 2017-07-14, Balance as of period end |
| 2015-03-31 | $824.5K | -19.7% | 2016-07-14, Balance as of period end |
| 2014-03-31 | $1.03M | -3.6% | 2015-07-14, Balance as of period end |
| 2013-03-31 | $1.06M | +89.1% | 2014-07-15, Balance as of period end |
| 2012-03-31 | $562.9K | -64.4% | 2014-07-15, Balance as of period end |
| 2011-03-31 | $1.58M | n/a | 2012-07-16, Balance as of period end |